Affordable Access

deepdyve-link
Publisher Website

HCV in the Hemodialysis Population: treat now or later?

Authors
  • Martin, Paul1
  • Jadoul, Michel2
  • Pol, Stanislas3
  • 1 University of Miami School of Medicine, Department of Medicine, Division of Digestive and Liver Diseases, 1120 NW 14th Street, Miami, Florida, 33136.
  • 2 Department of Nephrology, Cliniques universitaires Saint-Luc, Université Catholique de Louvain, B-1200, Brussels, Belgium. , (Belgium)
  • 3 Université de Paris, Département d'Hépatologie, Hôpital Cochin, APHP; INSERM U1223, Institut Pasteur, Paris, France. , (France)
Type
Published Article
Journal
Journal of Viral Hepatitis
Publisher
Wiley (Blackwell Publishing)
Publication Date
Oct 24, 2019
Identifiers
DOI: 10.1111/jvh.13224
PMID: 31652366
Source
Medline
Keywords
Language
English
License
Unknown

Abstract

Hepatitis C virus (HCV) infection remains commoner in patients with chronic kidney disease (CKD) than the population at large1 . In the hemodialysis (HD) population HCV infection in part reflects acquisition of infection within dialysis units where its transmission can be effectively prevented by meticulous attention to body fluid precautions 2 . A series of studies have confirmed that HCV transmission on HD reflects lack of adherence to these precautions 3 . In contrast to the prevention of hepatitis B transmission in this setting, dedicated dialysis machines for HCV infected patients are not recommended4 . The likelihood of HCV acquisition while on HD is increased in units with a higher background prevalence of HCV infection so an infected HD patient also places others at risk. © 2019 John Wiley & Sons Ltd.

Report this publication

Statistics

Seen <100 times